Literature DB >> 29065820

Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.

Maricela Viola-Rhenals1, Kush R Patel2, Laura Jaimes-Santamaria1, Guojun Wu2, Jinbao Liu3, Q Ping Dou2,3.   

Abstract

BACKGROUND: Considerable evidence demonstrates the importance of dithiocarbamates especially disulfiram as anticancer drugs. However there are no systematic reviews outlining how their metal-binding ability is related to their anticancer activity. This review aims to summarize chemical features and metal-binding activity of disulfiram and its metabolite DEDTC, and discuss different mechanisms of action of disulfiram and their contributions to the drug's anticancer activity.
METHODS: We undertook a disulfiram-related search on bibliographic databases of peerreviewed research literature, including many historic papers and in vitro, in vivo, preclinical and clinical studies. The selected papers were carefully reviewed and summarized.
RESULTS: More than five hundreds of papers were obtained in the initial search and one hundred eighteen (118) papers were included in the review, most of which deal with chemical and biological aspects of Disulfiram and the relationship of its chemical and biological properties. Eighty one (81) papers outline biological aspects of dithiocarbamates, and fifty seven (57) papers report biological activity of Disulfiram as an inhibitor of proteasomes or inhibitor of aldehyde dehydrogenase enzymes, interaction with other anticancer drugs, or mechanism of action related to reactive oxygen species. Other papers reviewed focus on chemical aspects of dithiocarbamates.
CONCLUSION: This review confirms the importance of chemical features of compounds such as Disulfiram to their biological activities, and supports repurposing DSF as a potential anticancer agent. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Disulfiram; anticancer drug; dithiocarbamate; metal; new use of old drugs.; proteasome inhibitor

Mesh:

Substances:

Year:  2018        PMID: 29065820      PMCID: PMC6873226          DOI: 10.2174/0929867324666171023161121

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  99 in total

1.  Role of peroxidases, thiols and Bak/Bax in tumor cell susceptibility to Cu[DEDTC]2.

Authors:  Maricela Viola-Rhenals; Mary Strasberg Rieber; Manuel Rieber
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

2.  Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper.

Authors:  C I Nobel; M Kimland; B Lind; S Orrenius; A F Slater
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

3.  Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.

Authors:  Y R Chen; A Shrivastava; T H Tan
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

Review 4.  Advances in metal-induced oxidative stress and human disease.

Authors:  Klaudia Jomova; Marian Valko
Journal:  Toxicology       Date:  2011-03-23       Impact factor: 4.221

5.  Molecular mechanisms of apoptosis and cell selectivity of zinc dithiocarbamates functionalized with hydroxyethyl substituents.

Authors:  Yee Seng Tan; Kah Kooi Ooi; Kok Pian Ang; Abdah Md Akim; Yoke-Kqueen Cheah; Siti Nadiah Abdul Halim; Hoi-Ling Seng; Edward R T Tiekink
Journal:  J Inorg Biochem       Date:  2015-06-09       Impact factor: 4.155

Review 6.  Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress.

Authors:  Lars-Oliver Klotz; Klaus-Dietrich Kröncke; Darius P Buchczyk; Helmut Sies
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

7.  The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.

Authors:  Yong Hwan Han; Woo Hyun Park
Journal:  Oncol Rep       Date:  2009-08       Impact factor: 3.906

8.  Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease.

Authors:  Sukhdev S Brar; Claude Grigg; Kimberly S Wilson; Walter D Holder; Didier Dreau; Catherine Austin; Mareva Foster; Andrew J Ghio; A Richard Whorton; Grayson W Stowell; Linda B Whittall; Robert R Whittle; David P White; Thomas P Kennedy
Journal:  Mol Cancer Ther       Date:  2004-09       Impact factor: 6.261

9.  Separation of heavy metal from water samples--The study of the synthesis of complex compounds of heavy metal with dithiocarbamates.

Authors:  Sonila Kane; Pranvera Lazo; Fatos Ylli; Trajce Stafilov; Flora Qarri; Elda Marku
Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng       Date:  2016-01-13       Impact factor: 2.269

10.  Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.

Authors:  Joanna Triscott; Cathy Lee; Kaiji Hu; Abbas Fotovati; Rachel Berns; Mary Pambid; Margaret Luk; Richard E Kast; Esther Kong; Eric Toyota; Stephen Yip; Brian Toyota; Sandra E Dunn
Journal:  Oncotarget       Date:  2012-10
View more
  20 in total

1.  Effect of copper on the antifungal activity of disulfiram (Antabuse®) in fluconazole-resistant Candida strains.

Authors:  Claire N Shanholtzer; Cameron Rice; Katherine Watson; Hannah Carreon; Timothy E Long
Journal:  Med Mycol       Date:  2022-03-17       Impact factor: 4.076

Review 2.  The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Hallie M Blevins; Yiming Xu; Savannah Biby; Shijun Zhang
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

Review 3.  Connecting copper and cancer: from transition metal signalling to metalloplasia.

Authors:  Eva J Ge; Ashley I Bush; Angela Casini; Paul A Cobine; Justin R Cross; Gina M DeNicola; Q Ping Dou; Katherine J Franz; Vishal M Gohil; Sanjeev Gupta; Stephen G Kaler; Svetlana Lutsenko; Vivek Mittal; Michael J Petris; Roman Polishchuk; Martina Ralle; Michael L Schilsky; Nicholas K Tonks; Linda T Vahdat; Linda Van Aelst; Dan Xi; Peng Yuan; Donita C Brady; Christopher J Chang
Journal:  Nat Rev Cancer       Date:  2021-11-11       Impact factor: 69.800

4.  Posterior Reversible Encephalopathy Syndrome Instigated by Off-Label Disulfiram Use for Metastatic Melanoma.

Authors:  David R Beam; Jennifer M Knight
Journal:  Psychosomatics       Date:  2019-09-17       Impact factor: 2.386

5.  Antibacterial Effects of Disulfiram in Helicobacter pylori.

Authors:  Tomomi Kobatake; Keiki Ogino; Hiroyuki Sakae; Kazuyoshi Gotoh; Akari Watanabe; Osamu Matsushita; Hiroyuki Okada; Kenji Yokota
Journal:  Infect Drug Resist       Date:  2021-05-12       Impact factor: 4.003

6.  A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.

Authors:  Kristen C Kelley; Kenneth F Grossman; Mary Brittain-Blankenship; Kelli M Thorne; Wallace L Akerley; Moises C Terrazas; Ken M Kosak; Kenneth M Boucher; Saundra S Buys; Kimberly A McGregor; Theresa L Werner; Neeraj Agarwal; John R Weis; Sunil Sharma; John H Ward; Thomas P Kennedy; Douglas W Sborov; Paul J Shami
Journal:  BMC Cancer       Date:  2021-05-07       Impact factor: 4.430

Review 7.  Drug Repositioning With an Anticancer Effect: Contributions to Reduced Cancer Incidence in Susceptible Individuals.

Authors:  Sungpil Yoon; Hyung Sik Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

8.  Evaluation of the effects of disulfiram, an alcohol-aversive agent with anti-cancer activity, on mouse bone marrow cells.

Authors:  Seo-Ro Park; Hong-Gu Joo
Journal:  Korean J Physiol Pharmacol       Date:  2022-05-01       Impact factor: 2.016

Review 9.  Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Authors:  Vinayak Palve; Yi Liao; Lily L Remsing Rix; Uwe Rix
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

10.  Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line.

Authors:  Kate Butcher; Vinodh Kannappan; Rajagopal Sharada Kilari; Mark R Morris; Christopher McConville; Angel L Armesilla; Weiguang Wang
Journal:  BMC Cancer       Date:  2018-07-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.